Nordic Life Science 1
F R OM GL O BA L I Z A T I ON TO G E O P O L I T
I C S SPECIAL REPORT THE CHANGING WORLD O2 O1 O4 O3 01. USA Ellen Delisio writes about the consequences the new US administration has had, and could have, on the country's life science industry, research and development, and public health. READ MORE ON PAGE 26 02. EUROPE Europe is falling behind when it comes to R&D and innovaton. Complex regulations, a fragmented market, scattered funding, and potential tariffs are just some of the challenges ahead. READ MORE ON PAGE 32 03. CHINA In a sector long dominated by the US and Europe, Mainland China is now catching up in global pharma and biotechnology. Alexandra Hoegberg takes a closer look at China's life science industry. READ MORE ON PAGE 38 04. THE NORDICS How will the pharmaceutical stockpiling work in practice? Katarina Gabrielson, CEO, Oriola, writes about preparedness for a new era, clear roles and Nordic collaboration. READ MORE ON PAGE 44 NORDICLIFESCIENCE.ORG | 25 PHOTO DAVID LAGERLÖF PHOTO SINI PENNANEN